Health-related quality of life in Egyptian patients after liver transplantation

Annals of Hepatology

Volumn 11, Issue 6, 2012, Pages 882-890

  Mabrouk, Mahasen ^a   Esmat, Gamal ^a,b   Yosry, Ayman ^a,b   El Serafy, Magdy ^a,b   Doss, Wahid ^a,b   Zayed, Naglaa ^a   El Sahhar, Medhat ^c   Awny, Sally ^c   Omar, Ashraf ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b 6th Of October City   (Egypt)

^c Police Authority Hospital   (Egypt)

Author keywords

LDLT SF 36 Egypt; LDQOL 1.0 questionnaire; Liver transplant recipients

Indexed keywords

ADULT; ARTICLE; CADAVER DONOR; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EGYPT; EGYPTIAN; ETHNIC GROUP; FEMALE; GRAFT REJECTION; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE QUALITY OF LIFE 1.0 QUESTIONNAIRE; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT INFECTION; SHORT FORM 36; TREATMENT OUTCOME;

EID: 84869381697     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31414-0     Document Type: Article

References (46)

1. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, Mazariegos GV. Liver and intestine trans-plantation in the United States 1998-2007. Am J Trans-plant 2009; 9: 907-31.
2. van Ginneken BT, van den Berg-Emons RJ, van der Windt A, Tilanus HW, Metselaar HJ, Stam HJ, Kazemier G. Persis-tent fatigue in liver transplant recipients: a two-year fo-llow-up study. Clin Transplant 2010; 24: E10-E16.
3. Karam V, Castaing D, Danet C, Delvart V, Gasquet I, Adam R, Azoulay D, et al. Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver Transpl 2003; 9: 703-11.
4. Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, et al. Pretransplant variables associated with quality of life in liver transplant recipients. Liver Int 2008; 28: 1087-94.
5. Goetzmann L, Klaghofer R, Wagner-Huber R, Halter J, Boehler A, Muellhaupt B, Schanz U, et al. Psychosocial vulne-rability predicts psychosocial outcome after an organ trans-plant: results of a prospective study with lung,liver, and bone-marrow patients. J Psychosom Res 2007; 62: 93-100.
6. Goetzmann L, Klaghofer R, Wagner-Huber R, Halter J, Boehler A, Muellhaupt B, Schanz U, et al. Quality of life and psychosocial situation before and after a lung, liver or an allogeneic bone marrow transplant. Swiss Med Wkly 2006; 136: 281-90.
7. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Ar-tinian L, Kim S, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease-the LDQOL 1.0. Am J Gas-troenterol 2000; 95: 3552-65.
8. Schulz KH, Kroencke S, Ewers H, Schulz H, Younossi ZM. The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ). Qual Life Res 2008; 17: 575-84.
9. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepati-tis C. Qual Life Res 1998; 7: 39-55.
10. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
11. Araya V, Rakela J, Wright T. Hepatitis C after orthotopic li-ver transplantation. Gastroenterology 1997; 112: 575-82.
12. Tome S, Wells JT, Said A, Lucey MR. Quality of life after li-ver transplantation. A systematic review. J Hepatol 2008; 48: 567-77.
13. Jay CL, Butt Z, Ladner DP, Skaro AI, Abecassis MM. A re-view of quality of life instruments used in liver transplan-tation. J Hepatol 2009; 51: 949-59.
14. Strauss E, Dias Teixeira MC. Quality of life in hepatitis C. Liver Int 2006; 26: 755-65.
15. Russell RT, Feurer ID, Wisawatapnimit P, Lillie ES, Cas-taldo ET, Pinson CW. Profile of health-related quality of life outcomes after liver transplantation: univariate effects and multivariate models. HPB (Oxford) 2008; 10: 30-7.
16. Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, et al. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. Liver Transpl 2011; 17: 580-90.
17. Dan AA, Younossi ZM. Long-term improvement in health-related quality of life after orthotopic liver transplanta-tion. Liver Transpl 2008; 14: 1404-5.
18. Kousoulas L, Neipp M, Barg-Hock H, Jackobs S, Strass-burg CP, Klempnauer J, Becker T. Health-related quality of life in adult transplant recipients more than 15 years after orthotopic liver transplantation. Transpl Int 2008; 21: 1052-8.
19. Unal G, de Boer JB, Borsboom GJ, Brouwer JT, Essink-Bot M, de Man RA. A psychometric comparison of health-rela-ted quality of life measures in chronic liver disease. J Clin Epidemiol 2001; 54: 587-96.
20. Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician derived disease severity indices associa-ted with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol 2004; 99: 1726-32.
21. Sherman KE, Sherman SN, Chenier T, Tsevat J. Health va-lues of patients with chronic hepatitis C infection. Arch Intern Med 2004; 164: 2377-82.
22. Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant reci-pients. Liver Transpl 2001; 7: 213-9.
23. Feurer ID, Speroff T, Harrison C, Wright Pinson C. Heal-threlated quality of life before and after solid organ trans-plantation. Measurement consideration, reported outcomes, and future directions. Minerva Chir 2002; 57: 257-71.
24. Lembrança L, Medina J, Portugal M, Almeida D, Solla J, Ga-delha R, de Freitas LA, Paraná R. Epidemiological assess-ment of liver disease in northeastern Brazil by means of a standardized liver biopsy protocol. Ann Hepatol 2011; 10: 43-9.
25. Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, et al. Outcome of living donor liver trans-plantation for Egyptian patients with hepatitis C (geno-type 4)-related cirrhosis. Transplant Proc 2008; 40: 1481-4.
26. Yosry A, Abdel-Rahman M, Esmat G, El-Serafy M, Omar A, Doss W, Zayed N, et al. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients. Exp Clin Transplant 2009; 7: 157-63.
27. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005; 11: 218-23.
28. Gotardo DR, Strauss E, Teixeira MC, Machado MC. Liver transplantation and quality of life: relevance of a specific liver disease questionnaire. Liver Int 2008; 28: 99-106.
29. Castaldo ET, Feurer ID, Russell RT, Pinson CW. Correlation of health-related quality of life after liver transplant with the Model for End-Stage Liver Disease score. Arch Surg 2009; 144: 167-72.
30. Arguedas MR, De Lawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003; 48: 1622-6.
31. Feurer ID, Moore DE, Speroff T, Liu H, Payne J, Harrison C, Pinson CW. Refining a healthrelated quality of life as-sessment strategy for solid organ transplant patients. Clin Transplant 2004; 18(Suppl. 12): 39-45.
32. Younossi ZM, McCormick M, Price LL, Boparai N, Farquhar L, Henderson JM, Guyatt G. Impact of liver transplanta-tion on health-related quality of life. Liver Transpl 2000; 6: 779-83.
33. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Pa-tch D, Burroughs AK, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049-61.
34. Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepa-tology 2005; 41: 1407-32.
35. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006; 5: 77-85.
36. Fisher RA, Ham JM, Marcos A, Shiffman ML, Luketic VA, Kimball PM, Sanyal AJ, et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998; 66: 1616-21.
37. Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS. Tacrolimus (FK506) and mycophe-nolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 1998; 65: 180-7.
38. Dudley T, Chaplin D, Clifford C, Mutimer DJ. Quality of life after liver transplantation for hepatitis C infection. Qual Life Res 2007; 16: 1299-308.
39. Younossi Z, Kallma J, Dincaid J. The effects of HCV infec-tion and management on health-related quality of life. He-patology 2007; 45: 806-16.
40. Singh N, Gayowski T, Wagener MM, Marino IR. Quality of life, functional status, and depression in male liver trans-plant recipients with recurrent viral hepatitis C. Trans-plantation 1999; 67: 69-72.
41. Feurer ID, Wright JK, Payne JL, Kain AC, Wise PE, Hale P, Chapman WC, et al. Effects of hepatitis C virus infection and its recurrence after liver transplantation on functio-nal performance and health-related quality of life. J Gas-trointest Surg 2002; 6: 108-15.
42. Bownik H, Saab S. Health-related quality of life after liver transplantation for adult recipients. Liver Transpl 2009; 15 (Suppl. 2): S42-S49.
43. Bownik H, Saab S. The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients. Liver Int 2010; 30: 19-30.
44. Terrault NA, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 2006; 12: 1192-204.
45. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36: S237-S244.
46. Dias Teixeira MC, de Fatima Gomes de Sa Ribeiro M, Strauss E. A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL). Ann Hepatol 2005; 4: 264-71.